socalTECH

FEBRUARY 9, 2021

San Diego-based virtual reality startup Nanome, which is developing technology to help researchers explore the interaction of molecules and molecular compounds using VR, has raised $3M in a funding round, the company disclosed today.

San Diego 113

San Diego Venture Capital Research Tool 113

Xconomy

DECEMBER 5, 2018

Even as all eyes were on the American Society of Hematology (ASH) conference in downtown San Diego this week, other biotech companies were staying busy. Let’s get caught up with the latest life sciences news in San Diego. The San Diego biotech is developing therapies for cancers related to the Epstein-Barr virus.

San Diego 79

San Diego Conference News Develop 79

socalTECH

SEPTEMBER 8, 2021

San Diego-based Replicate Bioscience, which is looking to use self-replicating RNA (srRNA) to treat cancer, autoimmune, inflammatory disorders and other diseases, has raised $40M in its Series A funding. The funding was led by life sciences venture capital investor ATP. and Zachary Hartman, Ph.D.,

San Diego 113

San Diego Venture Capital Research Funding 113

socalTECH

SEPTEMBER 19, 2008

Venture capital firm Sofinnova Ventures has hired on an Executive-in-Residence based in San Diego, the firm said Thursday. Ekman is te former EVP and President of Global Research and Development at Elan Corporation. to its team.

San Diego 100

San Diego Venture Capital Research Capital 100

Xconomy

MAY 18, 2017

Preliminary findings from an economic impact study show that genomics is emerging as a distinct innovation cluster in San Diego. The San Diego Regional Economic Development Corp. began collecting data for the report earlier this year in a bid to assess how genomics fits into San Diego’s innovation economy.

Study 97

Study San Diego Venture Capital Press 97

socalTECH

SEPTEMBER 10, 2014

San Diego-based Avelas Biosciences , which is developing cell penetrating peptides to light up cancerous tissue in patients during surgery, has raised $7.4M The second tranche of the company''s Series B came from investors Avalon Ventures, Torrey Pines Investment and WuXi PharmaTech Investments. in a Series B funding.

Avalon 147

Avalon San Diego Venture Capital Research 147

socalTECH

AUGUST 5, 2021

San Diego-based Aardvark Therapeutics, a biopharmaceuticals company focused on metabolic diseases, said this morning that it has raised $29M in its Series B funding round. The company said the funding will go towards three Phase 2 clinical trails of its lead compound, and to advance several potential additional formulations.

San Diego 140

San Diego Research Funding Invest 140

socalTECH

NOVEMBER 3, 2021

San Diego-based Model Medicines, a company that is developing artificial intelligence and machine learning software for the drug discovery and development process, has raised $4.1M in a funding round. The funding came from 8VC, Irving Investors, Particle X and Nex Cubed.

Artificial Inteligence 133

Artificial Inteligence San Diego Research Platform 133

socalTECH

APRIL 29, 2021

San Diego- and Shanghai-based Adcentryx Therapeutics, a biotechnology company focused on antibody drug conjugate (ADC) therapeutic development, says it has raised $50M in its Series A funding round. The funding was led by CBC Group, and also included Zoo Capital the venture arm of Boyu Capital.

Funding 113

Funding San Diego Research Capital 113

socalTECH

MAY 26, 2021

San Diego-based Phanes Therapeutics, a developer of immuno-oncology drugs, has raised $40M in its Series B funding round. The funding was led by Sequoia Capital China, and also included the company other investors. Names of the other investors were not announced by the company. Ming Wang, PhD/MBA is CEO of Phanes Therapeutics.

San Diego 113

San Diego Research Funding Capital 113

TechCrunch LA

MARCH 22, 2018

We’ve also seen a substantial inflow of venture capital from all over the world.”. Our research revealed a saturation level causing unprecedented challenges, starting with exorbitant housing prices and runaway operating costs that accelerate a startup’s “burn rate”—its monthly spending.

Southern California 224

Southern California Dollar Shave Club SoCal Develop 224

Xconomy

DECEMBER 31, 2018

[ Editor’s Note: Euan Robertson, the Director of Strategic Planning & Special Projects at Columbia Technology Ventures, co-wrote this article.] It is a commonly held belief that academic research institutions, including those in New York City, are fierce competitors.

Research 96

Research Technology San Diego Develop 96

socalTECH

JANUARY 29, 2021

San Diego-based Encodia, a biotech company which is focused on proteomics research, has raised $75M in a Series C funding round, the company said this week.

San Diego 113

San Diego Research Capital Funding 113

socalTECH

MARCH 29, 2021

San Diego-based Fortis Therapeutics, a biotechnology startup developing treatments for late-stage prostate cancer and multiple myeloma, has raised $40M in a Series A financing, the company said on Monday.

Avalon 113

Avalon San Diego Research Funding 113

Xconomy

MARCH 13, 2018

At Intel Capital in the Bay Area, investment director Ranjeet Alexis is an expert in bioinformatics who is scouting for deals at the intersection of computation, healthcare, and the life sciences. His investments include Synthego , a provider of technology used in CRISPR genome editing and research.

San Diego 67

San Diego Artificial Inteligence Research Invest 67

socalTECH

JANUARY 21, 2021

San Diego- and New Jersey-based OncoSec Medical, a publicly traded biotechnology company focused on treatment of cancer, said today that it is raising $42.0M in a public offering of its common stock. The company said it is offering of 7,711,284 shares of its common stock at a price of $5.45, with an expected close on January 25th.

San Diego 113

San Diego Activity Research Pricing 113

socalTECH

JULY 28, 2021

San Diego-based immunology startup Aristea Therapeutics says it has raised $63M in a Series B financing round, which was led by Fidelity Management & Research Company, LLC, along with Novo Holdings A/S, plus Arena Pharmaceuticals and funds managed by Tekla Capital Management, LLC.

San Diego 100

San Diego Study Research Capital 100

socalTECH

JULY 29, 2014

PaxVax has its research, development, and manufacturing facilities in San Diego, although it is based in Redwood City. paxvax venture capital infectious disease vaccine debt financing lifescience' READ MORE>>.

San Diego 147

San Diego Equity Venture Capital Research 147

socalTECH

DECEMBER 22, 2020

San Diego-based Neomorph , a biotech startup focused on protein degradation, said today that it has raised $109M in a Series A funding. The company said it will use the Series A funding to further develop its platform, advance lead programs, and expand the research team. The funding came from Deerfield Management.

San Diego 113

San Diego Research Platform Funding 113

socalTECH

JULY 31, 2013

San Diego-based molecular diagnostics developer Trovagene announced this morning that it has raised $15M in a registered direct offering of its common stock. The company said the new funding will go towards research and development activities and for working capital and other general corporate purposes. READ MORE>>.

San Diego 138

San Diego Venture Capital Research Activity 138

socalTECH

DECEMBER 16, 2014

San Diego-based oncology drug developer Sorrento Therapeutics has scored a strategic investment from NantWorks , the biotech research company led by Dr. Patrick Soon-Shiong. sorrento therapeutics nantworks biotech lifescience venture capital strategic investment cancer immunotherapy' READ MORE>>.

Invest 147

Invest San Diego Venture Capital Research 147

socalTECH

APRIL 28, 2021

San Diego-based Boundless Bio, a company developing therapeutics for treating cancer, has raised $105M in its Series B funding, the company said this morning.

San Diego 113

San Diego Research Capital Invest 113

socalTECH

NOVEMBER 17, 2017

Tortuga Logic , a new startup focused on chip-level cybersecurity technology whose founders include professors from UC San Diego and UC Santa Barbara, has raised $2M in a seed funding, the company disclosed on Thursday. The seed funding came from Eclipse Ventures.

Software Review 124

Software Review UCSD Santa Barbara Seed Funding 124

socalTECH

JANUARY 8, 2021

San Diego-based Blacksmith Medicines, a new biotechnology company focused on creating medicines for immuno-oncology and inflammatory diseases by targeting human metalloenzymes, has raised a round of seed funding, and announced a research deal with Lilly. Financial details of that seed funding were not announced.

Seed Funding 113

Seed Funding Funding San Diego Research 113

socalTECH

MARCH 25, 2014

San Diego-based Assay Depot , which operates an online marketplace focused on scientific services, said this morning that it has raised $3M in a Series B funding round. The funding was led by Bootstrap Venture Fund. assay depot venture capital marketplace scientific service market' READ MORE>>.

Funding 124

Funding San Diego Venture Capital Research 124

socalTECH

JUNE 5, 2017

San Diego-based Comhear , a developer of immersive, 3D audio software, announced on Monday that it has raised $12M in a Series A funding. The company said its technology is based on research from the University of California San Diego (UCSD). Comhear develops audio enhancing software. READ MORE>>.

UCSD 147

UCSD San Diego Equity Research 147

socalTECH

JULY 13, 2020

San Diego-based biopharmaceuticals firm Poseida Therapeutics successfully made it to the public markets with an IPO on Friday, raising $224M in an offering on the Nasdaq Global Select Market. Poseida is backed by Fidelity Management Research Company, LLC, Adage Capital Management and Schonfeld Strategic Advisors, READ MORE>>.

San Diego 113

San Diego Research Pricing Capital 113

Xconomy

NOVEMBER 8, 2018

Dozens of research institutes. San Diego is one of the top U.S. Researchers and entrepreneurs here are leaders in developing the next generation of medicines and medical devices. Hundreds of companies. Billions of dollars in economic impact. cities for innovation in life sciences and healthtech.

San Diego 82

San Diego Research Tool Entrepreneur 82

socalTECH

MARCH 13, 2014

San Diego-based AnaptysBio , a biopharmaceuticals firm focused on the development of therapeutic antibodies, announced a deal today with TESARO. AnapytsBio is venture backed by Alloy Ventures, Avalon Ventures, Frazier Healthcare Ventures and Novo A/S. READ MORE>>.

Avalon 138

Avalon San Diego Venture Capital Research 138

socalTECH

JULY 20, 2021

San Diego-based Wugen, a biotechnology company which is developing treatments for solid tumors, recently annoucned a $172M, Series B funding round. Managing Partner at Abingworth, Bosun Hau, Managing Director at Tybourne Capital Management, and Peter Kiener, Ph.D., Bali Muralidhar, M.D.,

San Diego 113

San Diego Capital Research Platform 113

socalTECH

OCTOBER 19, 2017

My last company got acquired by Qualcomm, and Qualcomm wanted me to move to San Diego to run their emerging business portfolio. I then became and EIR at UC San Diego, and joined EvoNexus, the not-for-profit incubator run by the Irvine Company. As you know, Silicon Valley has a locker grip on the venture capital community.

Southern California 170

Southern California Venture Capital Startup Entrepreneur 170

socalTECH

SEPTEMBER 4, 2013

San Diego-based Triton Algae Innovations , a new startup whose founders include the co-founders of Sapphire Energy, Dr. Steve Mayfield and Dr. Jason Pyle, is announcing today that it has raised $5M in a Series A funding round. triton algae innovations synthetic biology protein venture capital biotech lifescience'

San Diego 147

San Diego Venture Capital Research Platform 147

socalTECH

SEPTEMBER 23, 2014

San Diego-based venture capital investor Avalon Ventures and biopharmaceuticals firm GlaxoSmithKline said Monday that the two have teamed up to fund and launch up to 10, early stage life science companies. According to Avalon Ventures and GSK, they will provide up to $495M to fund those ten new companies.

Avalon 100

Avalon San Diego Startup Venture Capital 100

socalTECH

JUNE 25, 2020

San Diego-based biopharmaceuticals developer Poseida Therapeutics has raised $110M more in funding, in its Series D round, the company announced this morning.

San Diego 113

San Diego Research Platform Sites 113

socalTECH

MAY 15, 2017

San Diego-based Scientist.com , a startup which operates a marketplace for outsourced research, has raised $24M in a funding round, the company announced Monday morning. The company--previously known as Assay Depot--is led by President and CEO Kevin Lustig, PhD. READ MORE>>.

Outsource 100

Outsource San Diego Research Hollywood 100

Xconomy

FEBRUARY 15, 2017

The final numbers on 2016 fintech funding deals are in from New York-based research firm and investment database CB Insights, and venture capitalists seem to be cooling on the industry. billion in venture capital across 836 investments last year. billion.

Venture Capital 59

Venture Capital Report Research Activity 59

Xconomy

JUNE 14, 2018

New immunotherapy approaches to cancer treatment, and the CRISPR technology for editing genetic material in cells, are among the most sophisticated research strategies scientists are using in their quest to defeat disease.

Research 74

Research Software Engineering Software Technology 74